https://clinicaltrials.gov/ct2/show/NCT04161807?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Condition : Chronic Migraine
Intervention : Device: Nerivio
Sponsor : Theranica
Recruiting
Efficacy and Safety of Nerivio™, a Remote Electrical Neuromodulation Device, for Acute Treatment of Migraine in People With Chronic Migraine: an Open Label, Single Arm, Multicenter Study
NCT04161807
Wed, 13 Nov 2019 12:00:00 EST
Last Update Posted: 11/13/19 12:03PM